These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25173702)

  • 1. Loco-regional cancer drug therapy: present approaches and rapidly reversible hydrophobization (RRH) of therapeutic agents as the future direction.
    Budker VG; Monahan SD; Subbotin VM
    Drug Discov Today; 2014 Dec; 19(12):1855-70. PubMed ID: 25173702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapidly reversible hydrophobization: an approach to high first-pass drug extraction.
    Monahan SD; Subbotin VM; Budker VG; Slattum PM; Neal ZC; Herweijer H; Wolff JA
    Chem Biol; 2007 Sep; 14(9):1065-77. PubMed ID: 17884638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of anticancer drugs.
    Zee-Cheng RK; Cheng CC
    Methods Find Exp Clin Pharmacol; 1989; 11(7-8):439-529. PubMed ID: 2689812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor targeting: activation of prodrugs by enzyme-monoclonal antibody conjugates.
    Huennekens FM
    Trends Biotechnol; 1994 Jun; 12(6):234-9. PubMed ID: 7765070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraperitoneal chemotherapy in the management of malignant disease.
    Markman M
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):142-8. PubMed ID: 12113122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The first generation of β-galactosidase-responsive prodrugs designed for the selective treatment of solid tumors in prodrug monotherapy.
    Legigan T; Clarhaut J; Tranoy-Opalinski I; Monvoisin A; Renoux B; Thomas M; Le Pape A; Lerondel S; Papot S
    Angew Chem Int Ed Engl; 2012 Nov; 51(46):11606-10. PubMed ID: 22996951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel prodrugs: toward smarter delivery of anticancer agents.
    Skwarczynski M; Hayashi Y; Kiso Y
    J Med Chem; 2006 Dec; 49(25):7253-69. PubMed ID: 17149855
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of pro-drug therapy in the treatment of cancer.
    Ferguson MJ; Ahmed FY; Cassidy J
    Drug Resist Updat; 2001 Aug; 4(4):225-32. PubMed ID: 11991677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assembly drug conjugates for anticancer treatment.
    Fumagalli G; Marucci C; Christodoulou MS; Stella B; Dosio F; Passarella D
    Drug Discov Today; 2016 Aug; 21(8):1321-9. PubMed ID: 27329268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curative and palliative aspects of regional chemotherapy in combination with surgery.
    Müller H; Hilger R
    Support Care Cancer; 2003 Jan; 11(1):1-10. PubMed ID: 12527948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial infusion chemotherapy for palliation in far-advanced malignant neoplasms.
    Hurlbut HJ; Sumner WC
    Am Surg; 1976 Feb; 42(2):116-22. PubMed ID: 55088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional cancer chemotherapy.
    Ensminger WD; Gyves JW
    Cancer Treat Rep; 1984 Jan; 68(1):101-15. PubMed ID: 6692422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
    Luo C; Sun J; Sun B; He Z
    Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles for delivery of chemotherapeutic agents to tumors.
    Vijayaraghavalu S; Raghavan D; Labhasetwar V
    Curr Opin Investig Drugs; 2007 Jun; 8(6):477-84. PubMed ID: 17621878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraperitoneal chemotherapy in the management of colon cancer.
    Markman M
    Semin Oncol; 1999 Oct; 26(5):536-9. PubMed ID: 10528901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small conjugate-based theranostic agents: an encouraging approach for cancer therapy.
    Kumar R; Shin WS; Sunwoo K; Kim WY; Koo S; Bhuniya S; Kim JS
    Chem Soc Rev; 2015 Oct; 44(19):6670-83. PubMed ID: 26118960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prodrugs in cancer chemotherapy.
    Connors TA; Knox RJ
    Stem Cells; 1995 Sep; 13(5):501-11. PubMed ID: 8528099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Loco-regional cancer chemotherapy with a new drug delivery system, "anticancer drug-fibrin clot"].
    Sugitachi A; Takatsuka Y; Numata N; Kawahara T; Hirata M; Kido T; Sakamoto I
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2814-7. PubMed ID: 2782891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loco-regional administration of nanomedicines for the treatment of lung cancer.
    Garrastazu Pereira G; Lawson AJ; Buttini F; Sonvico F
    Drug Deliv; 2016 Oct; 23(8):2881-2896. PubMed ID: 26585837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prodrug nanoassembly entrapping drugs as a tumor-targeted delivery system.
    Yuan Z; Yi X; Zhang J; Cheng S; Zhuo R; Li F
    Chem Commun (Camb); 2013 Jan; 49(8):801-3. PubMed ID: 23235958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.